{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:18:36Z","timestamp":1792268316691,"version":"4.4.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-82692"],"award-info":[{"award-number":["MOP-82692"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.neuropharm.2017.02.007","type":"journal-article","created":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T13:15:26Z","timestamp":1486732526000},"page":"209-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Effects of progesterone administered after MPTP on dopaminergic neurons of male mice"],"prefix":"10.1016","volume":"117","author":[{"given":"Nadhir","family":"Litim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Morissette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9r\u00e8se","family":"Di Paolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.02.007_bib1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/exnr.2001.7699","article-title":"Pegylated brain-derived neurotrophic factor shows improved distribution into the spinal cord and stimulates locomotor activity and morphological changes after injury","volume":"170","author":"Ankeny","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pneurobio.2016.03.010","article-title":"Astrocytes as a target for neuroprotection: modulation by progesterone and dehydroepiandrosterone","volume":"144","author":"Arbo","year":"2016","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib3","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1212\/WNL.55.9.1358","article-title":"Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging","volume":"55","author":"Baldereschi","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2017.02.007_bib4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrn1703","article-title":"Neurosteroids: endogenous regulators of the GABA(A) receptor","volume":"6","author":"Belelli","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations","volume":"20","author":"Bernheimer","year":"1973","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.yfrne.2009.04.014","article-title":"Neuroprotective actions of sex steroids in Parkinson's disease","volume":"30","author":"Bourque","year":"2009","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib7","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000438789","article-title":"Neuroprotective effect of progesterone in MPTP-treated male mice","volume":"103","author":"Bourque","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.neuropharm.2017.02.007_bib8","first-page":"558","article-title":"Biomarkers of glial cell proliferation and differentiation in culture","volume":"2","author":"Bramanti","year":"2010","journal-title":"Front. Biosci. Sch. Ed."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/1098-2396(20000915)37:4<245::AID-SYN1>3.0.CO;2-5","article-title":"Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice","volume":"37","author":"Callier","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2017.02.007_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/syn.1067","article-title":"Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl\/6 mice","volume":"41","author":"Callier","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2017.02.007_bib11","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.pbb.2011.06.012","article-title":"Progesterone prevents depression-like behavior in a model of Parkinson's disease induced by 6-hydroxydopamine in male rats","volume":"99","author":"Casas","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib12","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1179\/1743132812Y.0000000142","article-title":"Neuromodulatory effect of progesterone on the dopaminergic, glutamatergic, and GABAergic activities in a male rat model of Parkinson's disease","volume":"35","author":"Casas","year":"2013","journal-title":"Neurol. Res."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.neuroscience.2011.08.043","article-title":"Chronic progesterone treatment of male rats with unilateral 6-hydroxydopamine lesion of the dorsal striatum exacerbates [corrected] parkinsonian symptoms","volume":"196","author":"Chao","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.02.007_bib14","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neulet.2009.10.051","article-title":"Progesterone and dexamethasone differentially regulate the IGF-system in glial cells","volume":"468","author":"Chesik","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib15","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00011-009-0026-6","article-title":"The impact of age and gender on the striatal astrocytes activation in murine model of Parkinson's disease","volume":"58","author":"Ciesielska","year":"2009","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3389\/fnbeh.2015.00253","article-title":"Brain-derived neurotrophic factor serum levels correlate with cognitive performance in Parkinson's disease patients with mild cognitive impairment","volume":"9","author":"Costa","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/syn.10145","article-title":"Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice","volume":"47","author":"D'Astous","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2017.02.007_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4522(93)90175-F","article-title":"Glutathione peroxidase, glial cells and Parkinson's disease","volume":"52","author":"Damier","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.02.007_bib19","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.brainres.2013.07.014","article-title":"Progesterone's role in neuroprotection, a review of the evidence","volume":"1530","author":"Deutsch","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.yfrne.2013.03.001","article-title":"Neurosteroid and neurotransmitter alterations in Parkinson's disease","volume":"34","author":"di Michele","year":"2013","journal-title":"Front. Neuroendocrinol."},{"issue":"Pt 5","key":"10.1016\/j.neuropharm.2017.02.007_bib21","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson's disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2017.02.007_bib22","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Franklin","year":"1997"},{"key":"10.1016\/j.neuropharm.2017.02.007_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/glia.440110203","article-title":"Astrocytic GABA receptors","volume":"11","author":"Fraser","year":"1994","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2017.02.007_bib24","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1073\/pnas.91.11.5104","article-title":"Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat","volume":"91","author":"Frim","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib25","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0006-8993(93)90964-O","article-title":"Gonadal hormones down-regulate reactive gliosis and astrocyte proliferation after a penetrating brain injury","volume":"628","author":"Garcia-Estrada","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0736-5748(98)00065-3","article-title":"Dehydroepiandrosterone, pregnenolone and sex steroids down-regulate reactive astroglia in the male rat brain after a penetrating brain injury","volume":"17","author":"Garcia-Estrada","year":"1999","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib27","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1365-2826.2012.02284.x","article-title":"Neuroprotective effects of progesterone in chronic experimental autoimmune encephalomyelitis","volume":"24","author":"Giatti","year":"2012","journal-title":"J.\u00a0Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib28","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.expneurol.2006.08.019","article-title":"Progesterone modulates brain-derived neurotrophic factor and choline acetyltransferase in degenerating Wobbler motoneurons","volume":"203","author":"Gonzalez Deniselle","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib29","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.neuroscience.2004.02.024","article-title":"Progesterone up-regulates neuronal brain-derived neurotrophic factor expression in the injured spinal cord","volume":"125","author":"Gonzalez","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.02.007_bib30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00001756-200002070-00024","article-title":"Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice","volume":"11","author":"Grandbois","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2017.02.007_bib31","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/jnr.21848","article-title":"Regulation of the phosphoinositide-3 kinase and mitogen-activated protein kinase signaling pathways by progesterone and its reduced metabolites in the rat brain","volume":"87","author":"Guerra-Araiza","year":"2009","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib32","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib33","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0278-5846(89)90121-8","article-title":"Ageing and neurotoxins as causative factors in idiopathic Parkinson's disease\u2013a critical analysis of the neurochemical evidence","volume":"13","author":"Hornykiewicz","year":"1989","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.02.007_bib34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0304-3940(89)90445-X","article-title":"The biodisposition of MPP+ in mouse brain","volume":"101","author":"Irwin","year":"1989","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib35","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.neuroscience.2012.03.008","article-title":"Progesterone is neuroprotective against ischemic brain injury through its effects on the phosphoinositide 3-kinase\/protein kinase B signaling pathway","volume":"210","author":"Ishrat","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.02.007_bib36","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson's disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib37","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1016\/j.bbapap.2012.12.006","article-title":"The secretome signature of reactive glial cells and its pathological implications","volume":"1834","author":"Jha","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2017.02.007_bib38","article-title":"Progesterone changes VEGF and BDNF expression and promotes neurogenesis after ischemic stroke","author":"Jiang","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib39","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1210\/en.2008-1247","article-title":"The differences in neuroprotective efficacy of progesterone and medroxyprogesterone acetate correlate with their effects on brain-derived neurotrophic factor expression","volume":"150","author":"Jodhka","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2017.02.007_bib40","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.1460-9568.2005.03995.x","article-title":"The neuroprotective effect of progesterone after traumatic brain injury in male mice is independent of both the inflammatory response and growth factor expression","volume":"21","author":"Jones","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0014-4827(91)90532-Y","article-title":"Estrogen-inducible progesterone receptor in primary cultures of rat glial cells","volume":"193","author":"Jung-Testas","year":"1991","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib42","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0960-0760(92)90394-X","article-title":"Demonstration of steroid hormone receptors and steroid action in primary cultures of rat glial cells","volume":"41","author":"Jung-Testas","year":"1992","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib43","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1002\/jnr.21370","article-title":"Progesterone increases brain-derived neuroptrophic factor expression and protects against glutamate toxicity in a mitogen-activated protein kinase- and phosphoinositide-3 kinase-dependent manner in cerebral cortical explants","volume":"85","author":"Kaur","year":"2007","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib44","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S1474-4422(16)30001-1","article-title":"Treating neurodegenerative disease before illness: a challenge for the 21st century","volume":"15","author":"Kieburtz","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib45","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0969-8051(96)00023-6","article-title":"Effects of dopaminergic drug treatments on in\u00a0vivo radioligand binding to brain vesicular monoamine transporters","volume":"23","author":"Kilbourn","year":"1996","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib46","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.expneurol.2011.06.001","article-title":"Progesterone attenuates astro- and microgliosis and enhances oligodendrocyte differentiation following spinal cord injury","volume":"231","author":"Labombarda","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib47","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.pneurobio.2003.09.001","article-title":"Neurosteroid modulation of GABAA receptors","volume":"71","author":"Lambert","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib48","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/glia.21087","article-title":"Astrocytes are GABAergic cells that modulate microglial activity","volume":"59","author":"Lee","year":"2011","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2017.02.007_bib49","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neuropharm.2015.05.015","article-title":"The 5alpha-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease","volume":"97","author":"Litim","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.02.007_bib50","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3892\/mmr.2014.1967","article-title":"Progesterone alters Nogo-A, GFAP and GAP-43 expression in a rat model of traumatic brain injury","volume":"9","author":"Liu","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib51","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ncpneuro0355","article-title":"Mechanisms of Disease: astrocytes in neurodegenerative disease","volume":"2","author":"Maragakis","year":"2006","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib52","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12031-011-9570-y","article-title":"Modifications of neuroactive steroid levels in an experimental model of nigrostriatal degeneration: potential relevance to the pathophysiology of Parkinson's disease","volume":"46","author":"Melcangi","year":"2012","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib53","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pneurobio.2013.07.006","article-title":"Levels and actions of progesterone and its metabolites in the nervous system during physiological and pathological conditions","volume":"113","author":"Melcangi","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib54","first-page":"19","article-title":"MPTP mouse models of Parkinson's disease: an update","volume":"1","author":"Meredith","year":"2011","journal-title":"J.\u00a0Park. Dis."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib55","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10571-009-9437-8","article-title":"Stage dependent effects of progesterone on motoneurons and glial cells of wobbler mouse spinal cord degeneration","volume":"30","author":"Meyer","year":"2010","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib56","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/jne.12004","article-title":"Progesterone attenuates several hippocampal abnormalities of the Wobbler mouse","volume":"25","author":"Meyer","year":"2013","journal-title":"J.\u00a0Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib57","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1749-6632.1998.tb08230.x","article-title":"The impact of gender and estrogen on striatal dopaminergic neurotoxicity","volume":"844","author":"Miller","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib58","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.neuroscience.2005.07.060","article-title":"Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration","volume":"138","author":"Morale","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.02.007_bib59","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/jnc.13684","article-title":"The astrocytic response to the dopaminergic denervation of the striatum","volume":"139","author":"Morales","year":"2016","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib60","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.mce.2008.04.008","article-title":"Estrogen and SERM neuroprotection in animal models of Parkinson's disease","volume":"290","author":"Morissette","year":"2008","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib61","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0301-0082(00)00014-9","article-title":"Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease","volume":"63","author":"Murer","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib62","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/00001756-200205070-00018","article-title":"Impact of progestins on estradiol potentiation of the glutamate calcium response","volume":"13","author":"Nilsen","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2017.02.007_bib63","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/14660820050515197","article-title":"A\u00a0phase I\/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis","volume":"1","author":"Ochs","year":"2000","journal-title":"Amyotroph. Lateral Scler. Other Mot. Neuron Disord."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib64","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1023\/A:1011981927620","article-title":"Combined use of carboxyl-directed protein pegylation and vector-mediated blood-brain barrier drug delivery system optimizes brain uptake of brain-derived neurotrophic factor following intravenous administration","volume":"15","author":"Pardridge","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib65","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1212\/WNL.62.11.2010","article-title":"Risk of Parkinson disease in women: effect of reproductive characteristics","volume":"62","author":"Ragonese","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2017.02.007_bib66","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/00207450108986528","article-title":"Astroglial and microglial reaction after a partial nigrostriatal degeneration induced by the striatal injection of different doses of 6-hydroxydopamine","volume":"109","author":"Rodrigues","year":"2001","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib67","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(16)00060-0","article-title":"Challenges of modifying disease progression in prediagnostic Parkinson's disease","volume":"15","author":"Salat","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib68","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1212\/WNL.52.7.1417","article-title":"The effect of estrogen replacement on early Parkinson's disease","volume":"52","author":"Saunders-Pullman","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2017.02.007_bib69","first-page":"540","article-title":"Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson's disease","volume":"257","author":"Scalzo","year":"2010","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib70","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/exnr.1997.6679","article-title":"Differential regulation of astrocytic mRNAs in the rat striatum after lesions of the cortex or substantia nigra","volume":"149","author":"Schauwecker","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib71","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0959-4388(99)80013-0","article-title":"Neurotrophin regulation of synaptic transmission","volume":"9","author":"Schuman","year":"1999","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib72","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1353-8020(02)00014-7","article-title":"Is there a connection between estrogen and Parkinson's disease?","volume":"8","author":"Shulman","year":"2002","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib73","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1385\/ENDO:14:3:407","article-title":"Ovarian hormones elicit phosphorylation of Akt and extracellular-signal regulated kinase in explants of the cerebral cortex","volume":"14","author":"Singh","year":"2001","journal-title":"Endocrine"},{"key":"10.1016\/j.neuropharm.2017.02.007_bib74","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.tins.2009.08.002","article-title":"Molecular dissection of reactive astrogliosis and glial scar formation","volume":"32","author":"Sofroniew","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib75","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.maturitas.2012.03.015","article-title":"Systematic review of progesterone use by midlife and menopausal women","volume":"72","author":"Spark","year":"2012","journal-title":"Maturitas"},{"key":"10.1016\/j.neuropharm.2017.02.007_bib76","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.neuro.2015.10.012","article-title":"Neuroprotective effect of Valeriana wallichii rhizome extract against the neurotoxin MPTP in C57BL\/6 mice","volume":"51","author":"Sridharan","year":"2015","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuropharm.2017.02.007_bib77","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1210\/en.2011-2177","article-title":"Progesterone increases the release of brain-derived neurotrophic factor from glia via progesterone receptor membrane component 1 (Pgrmc1)-dependent ERK5 signaling","volume":"153","author":"Su","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2017.02.007_bib78","first-page":"1","article-title":"Retrograde axonal degeneration in Parkinson disease","volume":"6","author":"Tagliaferro","year":"2016","journal-title":"J.\u00a0Park. Dis."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib79","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1212\/WNL.52.7.1427","article-title":"A\u00a0controlled trial of recombinant methionyl human BDNF in ALS: the BDNF Study Group (Phase III)","volume":"52","author":"TheBDNFStudyGroup","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2017.02.007_bib80","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000339822","article-title":"Membrane progesterone receptors: evidence for neuroprotective, neurosteroid signaling and neuroendocrine functions in neuronal cells","volume":"96","author":"Thomas","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.neuropharm.2017.02.007_bib81","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/aje\/kwg068","article-title":"Incidence of Parkinson's disease: variation by age, gender, and race\/ethnicity","volume":"157","author":"Van Den Eeden","year":"2003","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib82","doi-asserted-by":"crossref","first-page":"901082","DOI":"10.1155\/2013\/901082","article-title":"Serum brain-derived neurotrophic factor levels in different neurological diseases","volume":"2013","author":"Ventriglia","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib83","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/cne.21826","article-title":"Ultrastructural localization of extranuclear progestin receptors in the rat hippocampal formation","volume":"511","author":"Waters","year":"2008","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib84","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2047-9158-1-14","article-title":"Current advances in using neurotrophic factors to treat neurodegenerative disorders","volume":"1","author":"Weissmiller","year":"2012","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib85","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1529-8027.2001.01019.x","article-title":"A\u00a0double-blind placebo-controlled clinical trial of recombinant human brain-derived neurotrophic factor (rhBDNF) in diabetic polyneuropathy","volume":"6","author":"Wellmer","year":"2001","journal-title":"J.\u00a0Peripher. Nerv. Syst."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib86","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/jnnp.2003.020982","article-title":"Are men at greater risk for Parkinson's disease than women?","volume":"75","author":"Wooten","year":"2004","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"issue":"391\u2013402","key":"10.1016\/j.neuropharm.2017.02.007_bib87","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1016\/j.annemergmed.2006.07.932","article-title":"ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury","volume":"49","author":"Wright","year":"2007","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.neuropharm.2017.02.007_bib88","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1186\/cc6887","article-title":"Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial","volume":"12","author":"Xiao","year":"2008","journal-title":"Crit. Care"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817300527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817300527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:48:36Z","timestamp":1758437316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817300527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":88,"alternative-id":["S0028390817300527"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.02.007","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of progesterone administered after MPTP on dopaminergic neurons of male mice","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}